Home › Free Stock Grades › OLMA
Olema Pharmaceuticals, Inc. (OLMA) Stock Grade
OLMA · Healthcare
B
Market Cap
$2.2B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About Olema Pharmaceuticals, Inc.'s fundamentals
Olema Pharmaceuticals is a biotechnology company with a market capitalization of $2.2 billion that reported flat revenue growth year-over-year at 0.0%. The company posted a net loss in its latest annual statement, resulting in a net margin of 0.0%, and currently does not pay a dividend to shareholders. As a pre-profitability biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable.